You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ANAFRANIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Anafranil, and what generic alternatives are available?

Anafranil is a drug marketed by Specgx Llc and is included in one NDA.

The generic ingredient in ANAFRANIL is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Anafranil

A generic version of ANAFRANIL was approved as clomipramine hydrochloride by CHARTWELL RX on March 29th, 1996.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ANAFRANIL?
  • What are the global sales for ANAFRANIL?
  • What is Average Wholesale Price for ANAFRANIL?
Summary for ANAFRANIL
Drug patent expirations by year for ANAFRANIL
Drug Prices for ANAFRANIL

See drug prices for ANAFRANIL

Recent Clinical Trials for ANAFRANIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoPhase 2
The Nazareth Hospital, IsraelN/A
Tirat Carmel Mental Health CenterN/A

See all ANAFRANIL clinical trials

Pharmacology for ANAFRANIL

US Patents and Regulatory Information for ANAFRANIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Specgx Llc ANAFRANIL clomipramine hydrochloride CAPSULE;ORAL 019906-001 Dec 29, 1989 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Specgx Llc ANAFRANIL clomipramine hydrochloride CAPSULE;ORAL 019906-002 Dec 29, 1989 AB RX Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Specgx Llc ANAFRANIL clomipramine hydrochloride CAPSULE;ORAL 019906-003 Dec 29, 1989 AB RX Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.